Literature DB >> 15849237

Abnormal cardiac inflow patterns during postnatal development in a mouse model of Holt-Oram syndrome.

Yu-Qing Zhou1, Yonghong Zhu, Jonathan Bishop, Lorinda Davidson, R Mark Henkelman, Benoit G Bruneau, F Stuart Foster.   

Abstract

Tbx5(del/+) mice provide a model of human Holt-Oram syndrome. In this study, the cardiac functional phenotypes of this mouse model were investigated with 30-MHz ultrasound by comparing 12 Tbx5(del/+) mice with 12 wild-type littermates at 1, 2, 4, and 8 wk of age. Cardiac dimensions were measured with two-dimensional and M-mode imaging. The flow patterns in the left and right ventricular inflow channels were evaluated with Doppler flow sampling. Compared with wild-type littermates, Tbx5(del/+) mice showed significant changes in the mitral flow pattern, including decreased peak velocity of the left ventricular (LV) early filling wave (E wave), increased peak velocity of the late filling wave (A wave), and decreased or even reversed peak E-to-A ratio. The prolongation of LV isovolumic relaxation time was detected in Tbx5(del/+) neonates as early as 1 wk of age. In Tbx5(del/+) mice, LV wall thickness appeared normal but LV chamber dimension was significantly reduced. LV systolic function did not differ from that in wild-type littermates. In contrast, the Doppler flow spectrum in the enlarged tricuspid orifice of Tbx5(del/+) mice demonstrated increased peak velocities of both E and A waves and increased total time-velocity integral but unchanged peak E/A. In another 13 mice (7 Tbx5(del/+), 6 wild-type) at 2 wk of age, significant correlation was found between Tbx5 gene expression level in ventricular myocardium and LV filling parameters. In conclusion, the LV diastolic function of Tbx5(del/+) mice is significantly deteriorated, whereas the systolic function remains normal.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15849237     DOI: 10.1152/ajpheart.00027.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  19 in total

Review 1.  Emerging imaging techniques.

Authors:  Elliot R McVeigh
Journal:  Circ Res       Date:  2006-04-14       Impact factor: 17.367

2.  An evaluation of transmitral and pulmonary venous Doppler indices for assessing murine left ventricular diastolic function.

Authors:  Lijun Yuan; Tao Wang; Fang Liu; Ethan D Cohen; Vickas V Patel
Journal:  J Am Soc Echocardiogr       Date:  2010-06-29       Impact factor: 5.251

Review 3.  Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease.

Authors:  Alexander T Mikhailov; Mario Torrado
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

4.  Angiotensin Ⅱ Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4.

Authors:  Susumu Matsuda; Seiji Umemoto; Koichi Yoshimura; Shinichi Itoh; Tomoaki Murata; Tohru Fukai; Masunori Matsuzaki
Journal:  J Atheroscler Thromb       Date:  2015-03-05       Impact factor: 4.928

5.  Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI.

Authors:  Jianfeng Du; Jing Liu; Han-Zhong Feng; M M Hossain; Nariman Gobara; Chi Zhang; Yuejin Li; Pierre-Yves Jean-Charles; Jian-Ping Jin; Xu-Pei Huang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-11       Impact factor: 4.733

6.  Tbx5-dependent pathway regulating diastolic function in congenital heart disease.

Authors:  Yonghong Zhu; Anthony O Gramolini; Mark A Walsh; Yu-Qing Zhou; Cameron Slorach; Mark K Friedberg; Jun K Takeuchi; Hui Sun; R Mark Henkelman; Peter H Backx; Andrew N Redington; David H Maclennan; Benoit G Bruneau
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

7.  Modeling Human TBX5 Haploinsufficiency Predicts Regulatory Networks for Congenital Heart Disease.

Authors:  Irfan S Kathiriya; Kavitha S Rao; Giovanni Iacono; W Patrick Devine; Andrew P Blair; Swetansu K Hota; Michael H Lai; Bayardo I Garay; Reuben Thomas; Henry Z Gong; Lauren K Wasson; Piyush Goyal; Tatyana Sukonnik; Kevin M Hu; Gunes A Akgun; Laure D Bernard; Brynn N Akerberg; Fei Gu; Kai Li; Matthew L Speir; Maximilian Haeussler; William T Pu; Joshua M Stuart; Christine E Seidman; J G Seidman; Holger Heyn; Benoit G Bruneau
Journal:  Dev Cell       Date:  2020-12-14       Impact factor: 12.270

8.  Application of echocardiography on transgenic mice with cardiomyopathies.

Authors:  G Chen; Y Li; J Tian; L Zhang; P Jean-Charles; N Gobara; C Nan; J-P Jin; X P Huang
Journal:  Biochem Res Int       Date:  2012-05-21

9.  GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.

Authors:  Mohammad Hossein Noyan-Ashraf; M Abdul Momen; Kiwon Ban; Al-Muktafi Sadi; Yu-Qing Zhou; Ali M Riazi; Laurie L Baggio; R Mark Henkelman; Mansoor Husain; Daniel J Drucker
Journal:  Diabetes       Date:  2009-01-16       Impact factor: 9.461

10.  Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice.

Authors:  Meghan Sauvé; Kiwon Ban; M Abdul Momen; Yu-Qing Zhou; R Mark Henkelman; Mansoor Husain; Daniel J Drucker
Journal:  Diabetes       Date:  2010-01-22       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.